AGL Stock Recent News

agilon health's stock has surged over 165% YTD in 2025 despite a 77% decline since its 2021 IPO, driven by CMS rate hikes for 2026. The company faces challenges with significant operating losses and industry headwinds, but remains committed to value-based care over fee-for-service models. agilon's business model involves global capitation fees from health plan payors, focusing on Medicare Advantage through a network of physician partners.

Agilon (AGL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will participate in the BofA Securities 2025 Health Care Conference including a fireside chat presentation on Wednesday, May 14 at 1:00 PM Eastern Time. Interested investors and other parties may listen to a simultaneous webcast of the presentation by visiting the “Events & Presentations” section of agilon health's inve.

WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the first quarter 2025 after the market closes on Tuesday, May 6, 2025, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (833) 470-1428 for U.S. participants and +1 (404) 975-4839 for international pa.

Here is how Agilon Health (AGL) and Paragon 28, Inc. (FNA) have performed compared to their sector so far this year.

J.P. Morgan analyst Lisa C. Gill, with a Neutral rating, updated estimates for Agilon Health, Inc. AGL following fourth-quarter results posted last month.

Here is how Agilon Health (AGL) and Akero Therapeutics, Inc. (AKRO) have performed compared to their sector so far this year.

agilon health, inc. (NYSE:AGL ) Q4 2024 Earnings Conference Call February 25, 2025 4:30 PM ET Company Participants Evan Smith - Senior Vice President of Investor Relations Steven Sell - Chief Executive Officer Jeffrey Schwaneke - Chief Financial Officer Conference Call Participants Stephen Baxter - Wells Fargo Justin Lake - Wolfe Research Jack Slevin - Jefferies Ryan Langston - TD Cowen Amir Farahani - Bernstein Jailendra Singh - Truist Securities Michael Ha - Baird Elizabeth Anderson - Evercore Adam Ron - Bank of America Ryan Daniels - William Blair Whit Mayo - Leerink Partners Daniel Grosslight - Citi David Larsen - BTIG George Hill - Deutsche Bank Matt Shea - Needham Operator Hello and welcome to the agilon health Fourth Quarter 2024 Earnings Conference.

While the top- and bottom-line numbers for Agilon (AGL) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Agilon Health (AGL) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.22. This compares to loss of $0.41 per share a year ago.